JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barry, Y. A.
Right arrow Articles by Rock, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barry, Y. A.
Right arrow Articles by Rock, G.

The Journal of Thoracic and Cardiovascular Surgery, Vol 97, 900-905, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association

ARTICLES

Perioperative exposure to plasticizers in patients undergoing cardiopulmonary bypass

YA Barry, RS Labow, WJ Keon, M Tocchi and G Rock
Ottawa Centre, Canadian Red Cross, Blood Transfusion Service, Ontario, Canada.

Di(2-ethylhexyl)phthalate and its principal metabolite, mono(2- ethylhexyl)phthalate, are contaminants of blood that are extracted on contact with polyvinylchloride surfaces, such as blood collection bags and tubing used in cardiopulmonary bypass. In this study, levels of the two plasticizers were measured in patients who underwent coronary artery bypass grafting, orthotopic transplantation, implantation of the Jarvik 7-70 total artificial heart during bridge-to-transplant procedures, and in infants who underwent corrective operations for congenital defects. In all adult patients the levels of di(2- ethylhexyl)phthalate increased tenfold by the end of cardiopulmonary bypass, whereas the levels of mono(2-ethylhexyl)phthalate increased ninefold. In infants, levels of di(2-ethylhexyl)phthalate rose seven times by the end of bypass and mono(2-ethylhexyl)phthalate rose significantly as well. In most of the patients having coronary bypass, the two plasticizers declined to preoperative levels within 24 hours. However, in some of the patients having orthotopic transplantation and in those in whom the Jarvik 7-70 total artificial heart was used as a bridge to transplant, the levels were still detectable 120 hours postoperatively. Circulating levels of mono(2-ethylhexyl)phthalate are only 20- to 35-fold lower in patients undergoing cardiac operations than the level of mono(2-ethylhexyl)phthalate causing a 50% reduction in developed contractile force and arrhythmias in an in vitro human atrial trabecular preparation. This study shows that patients with multisystem failure and infants may be at risk for this acute exposure to mono(2-ethylhexyl)phthalate.


This article has been cited by other articles:


Home page
 PediatricsHome page
K. M. Shea and Committee on Environmental Health
Pediatric Exposure and Potential Toxicity of Phthalate Plasticizers
Pediatrics, June 1, 2003; 111(6): 1467 - 1474.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
J Horisberger, D Jegger, Y Boone, I Seigneul, N Pierrel, M Hurni, A F Corno, and L K von Segesser
Impact of a remote pump head on neonatal priming volumes
Perfusion, September 1, 1999; 14(5): 351 - 356.
[Abstract] [PDF]

Home page
 Toxicol Ind HealthHome page
Regulations and Advisories
Toxicology and Industrial Health, September 1, 1999; 15(8): 718 - 742.
[PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 by The American Association for Thoracic Surgery.